CLINICAL, HISTOPATHOLOGICAL, IMMUNOLOGICAL AND FIBROBLAST STUDIES IN 30 PATIENTS WITH SUBCUTANEOUS INJECTIONS OF MODELANTS INCLUDING SILICONE AND MINERAL-OILS
Ar. Cabral et al., CLINICAL, HISTOPATHOLOGICAL, IMMUNOLOGICAL AND FIBROBLAST STUDIES IN 30 PATIENTS WITH SUBCUTANEOUS INJECTIONS OF MODELANTS INCLUDING SILICONE AND MINERAL-OILS, Revista de Investigacion Clinica, 46(4), 1994, pp. 257-266
Objective. To study patients with side effects secondary to the inject
ion of modelants. Methods. We studied their clinical, serological, his
topathological, radiographic, immunoregulatory and fibroblast culture
features by standard methods. We studied thirty patients, 24 women, me
an age: 38.2 years. Patients had received either mineral oil, guayacol
, silicone or a mixture of these substances; some had received unknown
material(s). Results. The mean time between the injection and the ons
et of symptoms was six years (range: 0.1-24 years). All patients had s
clerodermatous skin changes, subcutaneous nodules, edema and/or hyperp
igmentation at the site(s) of injection(s); five individuals also had
skin changes at sites remote from the injection. Thirteen patients had
clinical features of an autoimmune disease. Eleven patients gave a hi
story of arthralgias including four that had symmetrical non-erosive p
olyarthritis. Twenty of 28 patients (71 %) had positive anti-nuclear a
ntibodies. We found intracellular spontaneous production of IL-1 (inte
rleukin-1) by patients' macrophages which was almost absent in normal
cells (p<0.001). Silica-stimulated monocytes from patients also secret
ed more IL-1 than those from normal subjects (p<0.001) in autologous m
ixed lymphocyte reaction. Twelve patients had an early proliferative r
esponse. At day seven, a decreased proliferative response was seen in
12/19 patients (p<0.001). Skin fibroblasts from 3/3 patients synthesiz
ed 3-to-5-fold more H-3-hyaluronic acid than normal control cells (p<0
.001). Conclusions. This report confirms the association between the i
njection of modelants and the development of autoimmune disease (human
adjuvant disease, HAD). Our results implicate IL-1 in the amplificati
on of the disease process. The similarities between primary scleroderm
a and human adjuvant disease now include immunological and connective
tissue data. The study of these patients may help to understand the et
iopathogenesis of some autoimmune diseases.